Scientific Reports · 2019 · 39 citations · 43 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsCell-based TherapeuticsCentral Nervous System Tumor PharmacotherapyGlioblastomaCancer Stem Cell - Mediated ResistanceCell Phenotype MaintenanceCell Viability AssaysCombination TherapyGlioblastoma Drug TherapyGlioblastoma Stem CellsGlioblastoma Therapeutic ResistanceTemozolomide Therapy
Cancer stem cells are associated with chemoresistance and rapid recurrence of malignant tumors, including glioblastoma (GBM). Although temozolomide (TMZ) is the most effective drug treatment for GBM, GBM cells acquire resistance and become refractory to TMZ during treatment. Therefore, glioma stem cell (GSC)-targeted therapy and TMZ-enhancing therapy may be effective approaches to improve GBM prognosis. Many drugs that suppress the signaling pathways that maintain GSC or enhance the effects of TMZ have been reported. However, there are no established therapies beyond TMZ treatment currently in use. In this study, we screened drug libraries composed of 1,301 existing drugs using cell viability assays to evaluate effects on GSCs, which led to selection of kenpaullone, a kinase inhibitor, as a TMZ enhancer targeting GSCs. Kenpaullone efficiently suppressed activity of glycogen synthase kinase (GSK) 3β. Combination therapy with kenpaullone and TMZ suppressed stem cell phenotype and viability of both GSCs and glioma cell lines. Combination therapy in mouse models significantly prolonged survival time compared with TMZ monotherapy. Taken together, kenpaullone is a promising drug for treatment of GBM by targeting GSCs and overcoming chemoresistance to TMZ.
43
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Identification of a cancer stem cell in human brain tumors.
Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki et al. · PubMed · 2003 · 4.9K citations
Medicine, Cell Biology, Oncology +17
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Olivier Chinot, Wolfgang Wick, Warren Mason et al. · New England Journal of Medicine · 2014 · 2.5K citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Gentao Liu, Xiangpeng Yuan, Patrizia Tunici et al. · Molecular Cancer · 2006 · 1.8K citations · Full text
Medicine, Cell Biology, Oncology +17
The specificities of protein kinase inhibitors: an update
Jenny Bain, Hilary McLauchlan, Matthew Elliott et al. · Biochemical Journal · 2003 · 1.4K citations · Full text